Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; July 2017, Vol. 5 Issue: 7 p568-576, 9p
- Subject
- Language
- ISSN
- 22132600; 22132619